alerts & publications
New York Law Journal: AI and Life Sciences Patents – Separating Myth From RealityMarch 20, 2020
O’Melveny partners Lisa Pensabene and Hassen Sayeed, counsel Carolyn Wall, and associate James Yi Li authored this bylined article, which separates myth from the reality of how AI will impact life sciences patent law.
“Fears that AI will replace human inventors contradict the current U.S. patent law framework and ignore the way that drugs are actually discovered,” the authors wrote. “That is not to say, however, that life science patent practitioners should expect to see all concerns about the impact of AI to fade away. Practitioners would do well to prepare—and prepare their clients—for how AI may change the legal landscape with respect to patent obviousness, written description, and enablement.”
Read the full article here.
Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.